Clinical Endocrinology · 1974 · 25 citations · 12 references
MedicineEndocrinologyOncologyEndocrine OncologyHormone BiochemistryNeuroendocrinologyGrowth HormonePituitary DisordersPituitary Gland FunctionPituitary HormonesPituitary TumorsThyroid DisordersHypothalamic DisordersHypothalamic FunctionPituitary DysfunctionSubclinical HypothyroidismThyroid Hormone PhysiologyThyroid Hormone SecretionThyroid-stimulating Hormone TestingThyrotropin Secretion
SUMMARY Plasma immunoreactive thyrotrophin (TSH) responses to synthetic thyrotrophin releasing hormone (TRH) have been measured in forty‐five patients with pituitary or hypothalamic disease (largely non‐functioning and functioning pituitary tumours) tested before and/or after ablative treatment. Subnormal TSH responses usually indicated impaired pituitary function but were less sensitive indices than those of human growth hormone (HGH) after hypoglycaemia. High basal TSH values with exaggerated rises after TRH were occasionally found with hypothyroidism and impaired HGH and cortisol secretion. Delayed TSH responses were indicative of hypothalamic disease in some cases, but in others were associated with pituitary tumours without overt hypothalamic disease. Normal TRH tests were found with hypothyroidism, while five abnormal tests (four delayed) were found in euthyroid patients. Patterns of TSH response to TRH in hypothalamic‐pituitary disease are complex and their significance is not always clear.
12
THE THYROTROPHIN-RELEASING HORMONE TEST IN DISEASES OF THE PITUITARY AND HYPOTHALAMUS
R. Hall, G. M. Besser, B. J. Ormston et al. · The Lancet · 1972 · 173 citations
Synthetic Thyrotropin-Releasing Hormone
Michael S. Anderson, Cyril Y. Bowers, Abba J. Kastin et al. · New England Journal of Medicine · 1971 · 173 citations
Norman Fleischer, Roger Burgus, Wylie Vale et al. · The Journal of Clinical Endocrinology & Metabolism · 1970 · 128 citations